Background Bone marrow mesenchymal stem cells (BM-MSCs) represent promising source for tissue engineering and cell therapy, due to their multipotency, immunoregulation and self-renewal properties [1,2]. The expansion phase of these cells prior to differentiation and/or injection to the patient remains a critical step. BM-MSCs are classically expanded in small scale culture systems, with low con...
